Publications
Last 10 CNLab publications:
1. H-Ferritin nanoparticle-mediated delivery of antibodies across a BBB in vitro model for treatment of brain malignancies. Rizzuto MA, Dal Magro R, Barbieri L, Pandolfi L, Sguazzini-Viscontini A, Truffi M, Salvioni L, Corsi F, Colombo M, Re F, Prosperi D. Biomater Sci. 2021 Feb 5. doi: 10.1039/d0bm01726d.
2. Oxidative Stress Boosts the Uptake of Cerium Oxide Nanoparticles by Changing Brain Endothelium Microvilli Pattern. Dal Magro R, Vitali A, Fagioli S, Casu A, Falqui A, Formicola B, Taiarol L, Cassina V, Marrano CA, Mantegazza F, Anselmi-Tamburini U, Sommi P, Re F. Antioxidants (Basel). 2021 Feb 9;10(2):266. doi: 10.3390/antiox10020266.
3. Post-Translational Modification Analysis of VDAC1 in ALS-SOD1 Model Cells Reveals Specific Asparagine and Glutamine Deamidation. Pittalà MGG, Reina S, Cubisino SAM, Cucina A, Formicola B, Cunsolo V, Foti S, Saletti R, Messina A. Antioxidants (Basel). 2020 Dec 2;9(12):1218. doi: 10.3390/antiox9121218.
4. An update of nanoparticle-based approaches for glioblastoma multiforme immunotherapy. Taiarol L, Formicola B, Magro RD, Sesana S, Re F. Nanomedicine (Lond). 2020 Aug;15(19):1861-1871. doi: 10.2217/nnm-2020-0132.
5. The Clustering of mApoE Anti-Amyloidogenic Peptide on Nanoparticle Surface Does Not Alter Its Performance in Controlling Beta-Amyloid Aggregation. Corti R, Cox A, Cassina V, Nardo L, Salerno D, Marrano CA, Missana N, Andreozzi P, Silva PJ, Stellacci F, Dal Magro R, Re F, Mantegazza F. Int J Mol Sci. 2020 Feb 5;21(3). pii: E1066. doi: 10.3390/ijms21031066.
6. Differential Exchange of Multifunctional Liposomes Between Glioblastoma Cells and Healthy Astrocytes via Tunneling Nanotubes. Formicola B, D'Aloia A, Dal Magro R, Stucchi S, Rigolio R, Ceriani M, Re F. Front Bioeng Biotechnol. 2019 Dec 12;7:403. doi: 10.3389/fbioe.2019.00403. eCollection 2019.
7. The synergistic effect of chlorotoxin-mApoE in boosting drug-loaded liposomes across the BBB.Formicola B, Dal Magro R, Montefusco-Pereira CV, Lehr CM, Koch M, Russo L, Grasso G, Deriu MA, Danani A, Bourdoulous S, Re F. J Nanobiotechnology. 2019 Nov 11;17(1):115. doi: 10.1186/s12951-019-0546-3.
8. Nanomedicine for the Treatment of Alzheimer's Disease. Formicola B, Cox A, Dal Magro R, Masserini M, Re F. J Biomed Nanotechnol. 2019 Oct 1;15(10):1997-2024. doi: 10.1166/jbn.2019.2837. Review.
9. The Extent of Human Apolipoprotein A-I Lipidation Strongly Affects the β-Amyloid Efflux Across the Blood-Brain Barrier in vitro. Dal Magro R, Simonelli S, Cox A, Formicola B, Corti R, Cassina V, Nardo L, Mantegazza F, Salerno D, Grasso G, Deriu MA, Danani A, Calabresi L, Re F. Front Neurosci. 2019 May 16;13:419. doi: 10.3389/fnins.2019.00419. eCollection 2019.
10. Evolution of Nanoparticle Protein Corona across the Blood-Brain Barrier. Cox A, Andreozzi P, Dal Magro R, Fiordaliso F, Corbelli A, Talamini L, Chinello C, Raimondo F, Magni F, Tringali M, Krol S, Jacob Silva P, Stellacci F, Masserini M, Re F. ACS Nano. 2018 Jul 24;12(7):7292-7300. doi: 10.1021/acsnano.8b03500. Epub 2018 Jul 2.